Currently available genetic tools do not allow researchers to upregulate ('Knock Up') the levels of a given protein while retaining its cell-type-specific regulation. As a result, we have limited ability to develop overexpression-related disease models, to study the contribution of single genes in diseases caused by copy number variations and to identify disease pathways for drug targets. Here we develop two approaches for endogenous gene upregulation: conditional Knock Up (cKU) utilizing the Cre/lox system, and CRISPR-Cas9 mediated gene Knock Up (KU) in wild-type mouse embryos and human cells. Using glial cell line derived neurotrophic factor (GDNF) as a proof of concept, we show that both approaches resulted in upregulation of endogenous GDNF levels without disturbing Gdnf's expression pattern. Furthermore, CNS-specific GDNF cKU resulted in dopaminergic abnormalities and schizophrenia-like phenotypes. Our results suggest that gene Knock Up can reveal unknown gene functions and provide novel entry points for studying neurological disease.
Background
Understanding how aberrations in gene functioning lead to diseases and how the activity of endogenous signalling pathways can be harnessed to lead to different phenotypic outcomes and therapies is one of the major challenges for biomedical research and drug industry. One of the obstacles along this path is our limited ability to upregulate specific genes in endogenous signalling pathways-either by genetic tools or pharmacological compounds-to study gene function and to identify the genes or pathways that are beneficial if upregulated in a disease. Knocking out a gene or reducing the activity of the encoded protein is relatively achievable with various genetic tools. However, increasing the expression of specific genes while maintaining their natural expression pattern is much more of a challenge.
Although transgenic animals and viral overexpression methods are widely used for this purpose, they usually result in gene expression levels that far exceed that of endogenous genes, and importantly, transgene expression patterns do not usually follow the expression of native genes 1 . Yet, human studies have shown that even as little as a 50-100% increase in endogenous gene expression levels or activity is sufficient to cause neurological disease [2] [3] [4] [5] . Importantly, many of the genes implicated in these diseases encode regulatory proteins with restricted spatiotemporal expression patterns, further limiting the use of transgenic overexpression tools. Therefore, a tool that would allow researchers to conditionally increase gene expression levels within a physiological range, while retaining the correct expression pattern and transcriptional regulation, would be useful in many fields of basic and biomedical research, as well as for drug development.
With this in mind, we reasoned that in order to maintain correct gene expression patterns, modifications should be targeted towards regions that regulate expression post-transcriptionally, i.e., at the level of mRNA or protein. We focused on the 3' untranslated region (3'UTR) , because this region is well known for its role in regulating mRNA stability 6 . We hypothesised that by conditionally replacing negative regulation elements residing in the 3'UTR we could 'Knock Up' endogenous gene expression levels without altering the gene's spatiotemporal expression pattern. For a proof of concept, we generated a conditional Knock Up (cKU) model for the neurotrophic factor GDNF (glial cell line-derived neurotrophic factor), whose levels we have previously shown to be negatively regulated through its 3'UTR in vitro and in vivo 7 . GDNF is critically important for the development of peripheral tissues, including the kidney [8] [9] [10] [11] . In addition, GDNF is a potent neurotrophic factor for midbrain dopamine neurons in culture 12 and promotes dopamine synthesis and dopaminergic neuron fibre outgrowth if applied ectopically into the brain 13 . Increased dopamine signalling is associated with different neuropsychiatric diseases, including schizophrenia, where increased levels of presynaptic dopamine in the striatum are commonly observed [14] [15] [16] . Therefore, we were particularly interested in the outcome of brain-specific elevation of endogenous GDNF levels on brain dopamine system function, and the potential relevance of altered dopamine signalling in the context of schizophrenia.
To be able to specifically increase GDNF expression in the brain, we utilized the FLEx cassette 17 to conditionally replace the Gdnf 3'UTR with a 3'UTR and polyadenylation signal derived from the bovine growth hormone (bGHpA), using Cre-mediated recombination. We found increased GDNF expression in GDNF cKU mice, while Gdnf expression sites appeared unchanged. Mice with endogenous GDNF upregulation in the central nervous system (CNS) exhibited increased presynaptic dopamine signalling in the striatum, and reduced dopamine levels and altered gene expression in prefrontal cortex, resembling findings from schizophrenic patients and animal models 14, 15, 18, 19 .
Interestingly, we found that reduction in prefrontal cortex dopamine levels can also be triggered by striatal upregulation of endogenous GDNF in adult mice using striatal AAV-Cre delivery. Finally, we asked if endogenous gene expression levels can be elevated in wild-type cells by 3'UTR editing. We found that excising inhibitory regions from the Gdnf 3'UTR using the CRISPR-Cas9 system increased endogenous GDNF expression levels in wild-type mouse embryos and in human cells. Taken together, our results suggest that gene Knock Up via 3'UTR editing is applicable to human cells and wild-type mice and can reveal novel information about gene function.
Results

Generation of conditional Knock Up (cKU) allele
Gene overexpression levels and pattern in transgenic animals are mainly dependent upon transgene copy number, specificity of used promoter, integration site, and epigenetic changes across generations.
As a result, the extent of overexpression and expression pattern of transgenes usually differ significantly from those of endogenous gene products 1 . Therefore, it can be difficult to draw conclusions about the functions of proteins, whose levels and expression pattern are tightly controlled.
We hypothesised that by conditionally preventing post-transcriptional negative regulation of mRNA levels by 3'UTR replacement, endogenous mRNA and protein levels could be increased without changing the gene's spatiotemporal expression pattern ( Fig. 1a ). We further hypothesised that by utilizing the Cre/lox system, an increase in endogenous gene levels could also be restricted to specific tissues or cell types. Notably, by only affecting post-transcriptional regulation, we expected that gene expression would not be induced in cells that do not normally express the gene (Fig. 1a ). To provide a proof of concept for the approach, we generated a conditional Knock Up (cKU) allele for glial cell line-derived neurotrophic factor (GDNF) by inserting a lacking GDNF have no kidneys [8] [9] [10] [11] , whereas endogenous GDNF overexpression in GDNF hypermorphic mice causes a severe reduction in kidney size due to reduced migration of progenitors from the ureteric bud tip to the ureteric bud trunk 21 , and other histological alterations 7 . We first crossed Gdnf cKU mice to a Pgk1-Cre mouse line, where Cre expression results in an early and uniform recombination 22 . We found that Gdnf mRNA and GDNF protein levels were significantly increased in the kidneys of Gdnf WT/cKU ;Pgk1-Cre mice compared to wild-type mice at postnatal day (P) 3 ( Fig. 2a-b) . Similar to what we previously observed in GDNF hypermorphs 7 , kidney size was severely reduced in mice expressing increased levels of GDNF ( Fig. 2c ).
Next, we crossed Gdnf cKU mice to a tamoxifen-inducible Esr1-Cre line 23 and administered tamoxifen to pregnant females at E10.5. At E14.5, in situ hybridization using RNAscope probes against Gdnf revealed a stronger signal in Gdnf wt/cKU ;Esr1-Cre mice compared to wild-type littermates, whereas Gdnf's expression pattern in these mice was normal ( Fig. 2d ). To measure Gdnf mRNA levels, tamoxifen was then injected on three consecutive days at E12.5-E14.5, and mice were dissected at P3. We found that Gdnf expression in the kidneys of Gdnf WT/cKU ;Esr1-Cre mice was increased by more than 4-fold compared to wild-type and Gdnf WT/cKU controls ( Fig. 2e ). Therefore, we conclude that the Gdnf cKU allele allows us to increase endogenous Gdnf expression at different stages of development, and, in line with our hypothesis, does not change normal Gdnf expression pattern. 
Gdnf cKU mice have schizophrenia-like features
We next crossed the Gdnf cKU mice to a Nestin-Cre-expressing mouse line 24 to restrict the increase in endogenous GDNF levels to cells expressing GDNF in the CNS from E11.5 onwards. In the adult nigrostriatal system, GDNF is mostly produced in a sparse population of striatal interneurons 25 that regulates striatal output 26 . We analysed Gdnf expression in the striatum of Gdnf cKU ;Nestin-Cre mice and found that both Gdnf mRNA and GDNF protein levels were increased in Gdnf cKU mice ( Fig. 3a and Extended Data Fig. 2a ), whereas Gdnf's expression pattern appeared normal (Fig. 3b ). In line with previous findings 7 , Gdnf cKU ;Nestin-Cre mice exhibited increased levels of total tissue dopamine in the striatum and substantia nigra (SN) ( Fig. 3c-d ) and increased evoked dopamine release and uptake in the striatum ( Fig. 3e-f ).
Increased striatal dopamine signalling, particularly in the dorsal striatum, is a hallmark of schizophrenia [14] [15] [16] . Furthermore, studies on schizophrenic patients and a mouse model overexpressing dopamine receptor D2 (Drd2) have suggested that increased dopamine signalling in the striatum results in reduced dopamine signalling in the prefrontal cortex (PFC) 18, 19 . We therefore asked if increased dopamine signalling in the striatum of Gdnf cKU ;Nestin-Cre mice alters dopamine levels in the prefrontal cortex. Indeed, we found that dopamine levels were markedly reduced in the PFC of Gdnf wt/cKU ;Nestin-Cre and Gdnf cKU/cKU ;Nestin-Cre mice at two months of age ( Fig. 4a ), indicating that an increase in presynaptic dopamine in the nigrostriatal system also leads to aberrant dopamine signalling in the PFC in our mouse model.
Studies on patients with schizophrenia have identified several changes in gene expression in the PFC.
In particular, reduced Drd2 expression in the PFC is associated with schizophrenia [27] [28] [29] [30] . We found that Drd2 mRNA levels were significantly reduced in the PFC of Gdnf wt/cKU ;Nestin-Cre (heterozygous) mice and Gdnf cKU/cKU ;Nestin-Cre (homozygous) mice ( Fig. 4b) . To obtain a more in-depth understanding of gene expression changes in the PFC, we performed RNA sequencing ( Fig. 4c ). We identified 311 differentially expressed (DE) genes in Gdnf wt/cKU ;Nestin-Cre mice and 214 genes in Gdnf cKU/cKU ;Nestin-Cre mice (Extended Data Fig. 2b-d) . Functional annotation highlighted genes belonging to Gene Ontology (GO) categories related to dopamine signalling and myelination as most enriched among DE genes ( Fig. 4d , Extended Data Fig. 2e ). Further analysis on the top 150 enriched GO categories revealed 10 distinct clusters of DE genes, mostly related to nervous system development and function ( Fig. 4e ). Moreover, we found that many of the DE genes have previously been associated with schizophrenia in either genome-wide association studies or based on gene expression changes in schizophrenic patients ( Fig. 4f and Extended Data Table 1 ), suggesting that the dysregulated pathways in Gdnf wt/cKU ;Nestin-Cre and Gdnf cKU/cKU ;Nestin-Cre mice share similarities with schizophrenia. To investigate the behavioural outcome of aberrant dopamine signalling and gene expression in the PFC of Gdnf cKU/cKU ;Nestin-Cre mice, we used the pre-pulse inhibition (PPI) test, which reflects the ability to successfully integrate and inhibit sensory information. Patients with schizophrenia and animal models with schizophrenia-like features have diminished responses to PPI 18, 19, [31] [32] [33] , which is believed to reflect impaired striatal and cortical dopamine transmission [32] [33] [34] . We found that the extent of PPI was significantly reduced in Gdnf cKU/cKU ;Nestin-Cre mice ( Fig. 4g ), suggesting that altered dopamine signalling is paralleled by a deficit in sensorimotor gating. Therefore, we conclude that a tissue-specific increase in endogenous GDNF expression in the CNS at midgestation results in a phenotypic resemblance to schizophrenic patients, suggested by increased presynaptic dopamine signalling in the striatum, reduced dopamine levels in the PFC, reduced expression of several genes and pathways identified in post-mortem samples from the PFC of schizophrenic patients, and a deficit in PPI, a known endophenotype of schizophrenia (Table 1) .
Adult-onset GDNF cKU affects PFC DA system
Given that schizophrenia symptoms usually start in adolescence or adulthood, we were interested in whether the schizophrenia-like features found in Gdnf wt/cKU ;Nestin-Cre and Gdnf cKU/cKU ;Nestin-Cre mice could also be induced upon an adult-onset increase of endogenous GDNF expression. To that end, we injected AAV-Cre bilaterally into the striata of adult Gdnf wt/cKU and Gdnf cKU/cKU mice (Fig. 5a ). We found that 2 months after AAV-Cre injection Gdnf expression was increased by more than 2-fold ( Fig.   5b ), resulting in an increase in dopamine release in response to a burst stimulus (Extended Data Fig.   3a ). At the same time, total levels of striatal dopamine were not significantly increased, and evoked dopamine release and uptake were not affected (Extended Data Fig. 3b-d ). However, dopamine levels in the PFC were significantly reduced by ~50% ( Fig. 5c ), suggesting that changes in PFC dopamine signalling can be triggered already by 2-fold increase in endogenous GDNF levels in the adult striatum and by relatively minor changes in striatal dopamine function. We also administered the PPI test but found no indication of deficits in sensorimotor gating at the tested time point (Fig. 5d ). Taken together, we propose that Gdnf cKU mice may present a useful tool for studying the pathologies and treatments arising from increased presynaptic striatal dopamine function, as well as for finding therapeutic strategies that specifically target this deficit in schizophrenia. The ability to upregulate endogenous gene expression in developing, adolescent and adult animals may also allow researchers to investigate the importance of timing the onset of altered protein levels, which could have relevance for certain nervous system diseases 37, 38 .
Phenotype
Gdnf cKU/cKU ; Nestin-Cre Gdnf cKU/cKU AAV-Cre Findings in humans Increased striatal DA levels
Reduced prefrontal cortex DA levels
Reduced PFC dopamine D2 receptor levels + n.a + [27] [28] [29] [30] Deficit in pre-pulse inhibition
3'UTR editing with CRISPR-Cas9
Conditional replacement of the 3'UTR is possible in experimental animals, but not applicable for tissue engineering or potential therapeutic uses. Based on the above findings on the conditional 3'UTR replacement, we hypothesised that removing inhibitory sequences from the endogenous 3'UTR via 3'UTR editing using the CRISPR-Cas9 system could result in the elevation of endogenous gene expression in vivo in wild-type animals.
To test this hypothesis, we decided to delete ~2.5 kb of the Gdnf 3'UTR central region from the Gdnf gene, which contains negative regulation sequences that destabilize Gdnf mRNA 7 . Guide RNAs (gRNAs) were designed to target the beginning and end of the genomic region corresponding to the Gdnf 3'UTR, removing most of the predicted microRNA (miR) binding sites, but leaving the translational stop signal and polyadenylation signal intact [Gdnf Knock Up (KU) allele, Fig. 6a ]. We hypothesised that the resulting transcript carrying a short 3'UTR with few miR binding sites would be more stable and lead to increased GDNF levels.
Mouse zygotes were microinjected at the one-cell stage with purified gRNAs and S. pyogenes Cas9 mRNA, and embryos were dissected at E18.5 for analysis of the kidneys and brain. In embryos carrying one or two Gdnf KU alleles (for detailed description on genotyping, please see the Methods section), the kidneys were notably smaller than kidneys from control animals ( Fig. 6b ) and, similar to kidneys from GDNF hypermorphs 7 and Gdnf wt/cKU ;Pgk1-Cre mice (Fig. 2c) , displayed disorganized cortex-medulla structure (Fig. 6c ). In line with these results, both Gdnf mRNA and GDNF protein levels were allele-dose-dependently increased in the kidneys of Gdnf wt/KU and Gdnf KU/KU mice ( Fig. 6de ). Furthermore, we found that Gdnf mRNA levels were also increased in the brains of Gdnf KU/KU mice ( Fig. 6f ). Finally, we found that 3'UTR editing increased Gdnf mRNA expression in the human embryonic kidney (HEK-293) cell line (Fig 6g) , suggesting that elevating endogenous gene expression via 3'UTR editing is also applicable to human cells.
Taken together, our data suggest that excising a long 3'UTR fragment from the Gdnf gene increases GDNF expression in human cells and mice. Importantly, the change in GDNF levels was achieved in human cells and wild-type mice without the introduction of a foreign sequence into the genome of the animals, suggesting that endogenous gene expression can also be elevated by editing the native 3'UTR of the gene. Therefore, this approach may be useful for identifying disease pathways in in vitro models and adult animals, as well as for developing treatment strategies for human disease.
Discussion
Currently, only 1-2% of the entire human proteome can be targeted by pharmacological agonists or activators, with the majority of targets being receptors, enzymes and transporter proteins 39, 40 . Many of the drugs have more than one target, making it difficult to pinpoint, which of the targets are responsible for treatment or for side-effects. Therefore, a tool that enables researchers to specifically Knock Up potential drug targets one at a time would assist in identifying endogenous pathways where upregulation is advantageous in disease models.
Elevation of endogenous protein expression due to copy number variations or mutations that alter regulatory sequences of genes contributes to many human diseases, including cancers, Alzheimer's disease, Parkinson's disease, autism and schizophrenia 37, [41] [42] [43] [44] [45] . Using the neurotrophic factor GDNF as a proof of concept example, we show that endogenous gene Knock Up is possible both by conditionally replacing the 3'UTR with a sequence not targeted by inhibitory factors, and by cleaving the negative regulatory regions of the native 3'UTR using the CRISPR-Cas9 system. We find no changes in celland developmental stage specific expression pattern of Gdnf, consistent with the notion that the Knock Up approach does not alter the chromatin context of the gene. This feature makes gene Knock Up different from transgenic overexpression, where epigenetic regulation of transgene expression is often affected by the integration site of the transgene. Furthermore, gene Knock Up also differs from transcriptional activation where a nuclease dead endonuclease is fused with a transcriptional activation domain 46 , because the latter, similarly to transgenic overexpression, is likely to induce ectopic gene expression in cells where the gene is not normally expressed.
We found that CNS-restricted elevation of endogenous GDNF led to several phenotypes associated with schizophrenia, including increased presynaptic dopamine levels in the striatum and SN, reduced dopamine levels in the PFC, associated changes in gene expression in the PFC, and impaired sensorimotor gating. Furthermore, adult-onset increase in striatal GDNF expression also reduced dopamine levels in the PFC. Several genetic association studies have implicated a link between GDNF and schizophrenia, although the results are inconclusive as yet (Extended Data Table 2 ). Our data suggests that a change in endogenous GDNF levels at a specific stage in development is sufficient to drive schizophrenia-like phenotypes in mice, hinting at the possibility that aberrant regulation of GDNF expression may also lead to detrimental consequences in humans.
Importantly, while GDNF Knock Up in the brain resulted in altered dopamine levels in both the striatum and prefrontal cortex, conditional knockdown of GDNF expression with the same Nestin-Cre mouse line did not alter total tissue dopamine levels in the PFC 47 . Therefore, the results of this study emphasise that downregulation and upregulation of endogenous gene expression do not always lead to opposite phenotypes, and thus both approaches are necessary to understand gene function.
Our results also illustrate how an increase in endogenous gene expression levels at different developmental ages can lead to different phenotypic outcomes. Mice with a constitutive increase in endogenous GDNF levels (Gdnf wt/hyper ) 7 and mice with constitutively active GDNF receptor RET protooncogene signalling (Ret MEN2B/MEN2B ) 48 have increased striatal dopamine levels, but no change in PFC dopamine levels 49 (Extended Data Fig. 3e ) and no deficit in PPI 50 . In accordance with this finding, patients with multiple endocrine neoplasia, type 2B (MEN2B), expressing constitutively active RET have not been reported to display neurological deficits or schizophrenia. At the same time, PFC dopamine levels in adult Gdnf cKU/cKU mice are dramatically reduced two months after endogenous GDNF upregulation in the striatum even with minor changes in striatal dopamine levels (Fig 5a-d) .
Therefore, the time of onset of an increase in endogenous gene expression clearly affects brain development and function, and methods like gene conditional Knock Up can assist in uncovering the function of endogenous genes at specific developmental time points.
The levels of more than one half of all protein-coding genes are predicted to be negatively regulated through the 3'UTR 51, 52 . Therefore-as also supported by results from a recent in vitro study 53 -3'UTR editing could be used to upregulate the expression of many or most of these genes in their native chromatin context. At the same time, it is increasingly recognised that 3'UTRs can have other functions, such as regulating mRNA localization or protein-protein interactions [54] [55] [56] , which are likely to limit the use of the 3'UTR editing for gene Knock Up. However, once relevant motifs are identified, it could be feasible to retain the sequences required for these other functions by selecting appropriate gRNAs for Cas9-mediated excision, or by incorporating those motifs into the FLEx cassette, thus expanding the list of potential target genes for the Knock Up approach.
Taken together, we believe that the described Knock Up modes: constitutive (Pgk1-Cre), tissue specific μ g of linearized targeting construct. After electroporation the cells were plated on 10-cm culture dishes and exposed to puromycin (1.5 μ g/ml; Sigma). Colonies were picked after 7-9 days of selection and grown on a 96-well plate. DNA isolated from ES cells was screened by long-range PCR for both 5' and 3' homologous arms. In total, 480 clones were screened.
Correct PCR products were verified by sequencing. Correctly targeted ES cells were injected into C57BL/N6 (Charles River Laboratories, MA, USA) mouse blastocysts to generate chimeric mice.
Germline transmission was achieved by breeding male chimeras with C57BL/N6 females. The Pgk1-puΔtk-bGHpA sequence was removed using CAG-Flp mouse line at F2 generation.
AAV production. Pseudotyped AAV2/5 vectors were produced using a double-transfection method with the appropriate transfer plasmid and the helper plasmid containing the essential adenoviral packaging genes, as described previously 57 Tamoxifen injection. For the analysis of Gdnf mRNA and protein levels, Gdnf wt/cKU mice were crossed to Esr1-Cre mice and pregnant females were injected i.p. with 25 mg/kg tamoxifen (Sigma-Aldrich) in corn oil on three consecutive days between E12.5-E14.5. The pups were dissected at P3 and tissues were isolated for further analysis. For RNAscope analysis, pregnant females were injected with 25 mg/kg tamoxifen at E10.5 and tissues were harvested at E14.5.
Pre-pulse inhibition. The PPI test was performed as described previously 50 . Male Gdnf cKU ;Nestin-Cre mice were analysed at an age of 3-4 months by experimenters blinded to the genotypes of the mice.
Littermates were used as controls.
gRNA design and production for zygote microinjection. Guide RNAs were designed using the CRISPR Design Tool (crispr.mit.edu) 58 and produced using overlap PCR 59 Two gRNAs were designed to target both the beginning (A, B) and the end (C, D) of the 3'UTR, while leaving the translational stop signal and putative polyadenylation signal intact (Fig. 6a) . All of the possible combinations (A+C, A+D, B+C and B+D) were used for zygote injections and the efficiencies of different combinations were comparable to each other (not shown). gRNA target sequences are shown in Extended Data Table 3 . Isolation of tissues. Pregnant females were deeply anesthetized with CO 2 , followed by cervical dislocation and decapitation, and embryos were dissected at indicated time points. P3 mice were sacrificed by decapitation. The kidneys were either immersed in 4% formaldehyde (Sigma, in 1× PBS) overnight, followed by dehydration and paraffinization (Leica ASP 200), or immediately snap frozen on dry ice and stored at -80 °C until analysed for mRNA and protein expression. Brains from E18.5 embryos were snap frozen and stored at -80 °C.
To isolate samples for biochemical analysis, adult mice were deeply anesthetized with CO 2 , followed by cervical dislocation and decapitation. The brain was quickly dissected and immersed in ice-cold PBS. Brain regions of interest were isolated from 2-mm slices cut using a brain matrix (Stoelting).
Tissue samples dedicated for RNA extraction or HPLC, as well as for kidney GDNF ELISA, were immediately snap frozen on dry ice and stored at -80 °C until processed. For GDNF ELISA, brain samples were immediately lysed in lysis buffer (see below) and stored at -80 °C until analysis.
To isolate samples for in situ hybridization, adult mice were anesthetized with pentobarbital (Mebunat, 200 mg/kg, i.p., Yliopiston Apteekki) and perfused with warm PBS and 4% formaldehyde. Samples were post-fixed in 4% formaldehyde for 24 hours at room temperature and paraffinised or dehydrated in 30% sucrose (Thermo Fisher Scientific) in PBS prior to sectioning.
RNA and protein isolation. Total RNA was isolated using Trizol Reagent (Thermo Fisher Scientific)
or RNAqueous Micro Kit (Thermo Fisher Scientific). Tissue samples for protein analysis were homogenized in lysis buffer prepared according to the recipe in the GDNF Emax Immunoassay System protocol (Promega). The tissue homogenate was centrifuged at 5000 rpm for 15 minutes at 4 °C and the supernatant was used immediately or stored at -80 °C until further processing. Each protein sample was only thawed and used once.
Genotyping. Genotyping samples were collected at weaning and/or during dissection. Genomic DNA was isolated from the tail using Extracta DNA Prep for PCR -tissue (Quanta Biosciences, USA).
Routine genotyping was performed using AccuStart II GelTrack PCR SuperMix (Quanta Biosciences, USA) and analysed by electrophoresis using 1.5-2% agarose gels in borate buffer. Primers used for genotyping the mice for the presence of Gdnf cKU allele are indicated on Extended Data Fig. 1a and Extended Data Table 3 .
Genotyping of tissues obtained from 3'UTR editing using the CRISPR-Cas9 posed a challenge due to mosaicism in analysed tissues. Because GDNF is not expressed ubiquitously, but rather in defined cell types at various stages of development, we were unable to rely on genotyping from the genomic DNA.
Instead, we used cDNA synthesised using random hexamer primers as a template for genotyping, to be able to specifically detect the presence of the cleaved allele in GDNF-expressing cells. To our surprise, the genotypes in the brain and kidney obtained from the same animals did not always coincide,
suggesting that Cas9-mediated DNA cleavage and repair had taken place after the cellular lineages for the particular cell types had separated. Primers used for genotyping the Gdnf KU allele are indicated in Extended Data Table 3 and Fig. 6a . Fastq files were aligned to the mouse reference genome (mm10) employing the STAR aligner 60 .
Reverse transcription and quantitative
Mapped reads from the subsequent bam files were counted in annotated exons using featureCounts 61 .
Reference genome sequence in fasta format and entrez gene annotations were retrieved from UCSC.
The resulting count table was imported to R/Bioconductor and differential gene expression analysis was carried out with edgeR 62 . Analysis was performed on genes that had 1 count per million (cpm) in at least 3 samples and normalised with TMM normalisation. Genes with an adjusted p-value under 0.05
were termed significant and were used for GO analysis using the topGO library 63 HPLC. The levels of dopamine and its metabolites were analysed as previously described 65 , using HPLC with electrochemical detection.
Histological analysis and in situ hybridization. For histological analysis, 5-μm paraffin sections were stained with Harris's hematoxylin (Merck) and eosin Y (Sigma-Aldrich), according to a routine protocol. RNA in situ hybridization was performed as previously described 7 . Briefly, fresh 5-μm paraffin sections from embryonic kidney or adult brain were hybridized with RNAscope 66 probes (Advanced Cell Diagnostics) detecting Gdnf mRNA, according to manufacturer's recommendations.
Sections were scanned with a Pannoramic 250 digital slide scanner (3D Histech).
Cell culture. gRNAs targeting the genomic region corresponding to human Gdnf 3'UTR were designed using the CRISPR Design Tool (crispr.mit.edu) 58 and are indicated in Extended Data Table 3 .
The gRNAs were cloned into pAAV-EF1a-eGFP 67 Fast-scan cyclic voltammetry. At 6-8 months of age, mice were decapitated, the brain was removed, and 300-μm-thick coronal slices containing the striatum were cut on a model 7000 smz-2 vibratome (Campden Instruments) in oxygen-bubbled (95% O2, 5% CO2) ice-cold cutting artificial cerebrospinal fluid (ACSF) containing the following (in mM): 75 NaCl, 2.5 KCl, 26 NaHCO3, 1.25 NaH2PO4, 2
MgCl2, 0.7 CaCl2, and 100 glucose. The slices were allowed to recover in a holding chamber for 20 min at 34°C, followed by 1-3 h at room temperature in oxygen-bubbled (95% O2, 5% CO2) recording ACSF containing the following (in mM): 119 NaCl, 3 KCl, 26 MgSO4, 1 KH2PO4, 1.2 MgCl2, 2
CaCl2, and 10 glucose. In the recording chamber, the slices were perfused continuously with oxygenbubbled recording ACSF. Fast-scan cyclic voltammetry recordings were performed using cylindrical 5 Nonparametric data was analysed with Kruskal-Wallis test, followed by Dunn's multiple comparison analysis. Statistical analysis was performed with GraphPad Prism v8. Quantitative PCR data was analysed as described previously 71 , using the geometric mean of reference genes for normalisation.
